STERIS plc Capital Expenditures
STERIS plc (STE) reported Capital Expenditures of $87.50 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-07.
Financial Statements › Cash Flow › Investing Activities
us-gaap:PaymentsToAcquirePropertyPlantAndEquipment · last filed 2026-08-07
- STERIS plc payments to acquire property, plant, and equipment for the quarter ending 2026-06-30 was $87.50M, a 6.52% decline year-over-year.
- STERIS plc payments to acquire property, plant, and equipment for the quarter ending 2026-03-31 was $90.20M, a 27.22% increase year-over-year.
- STERIS plc payments to acquire property, plant, and equipment for the quarter ending 2025-12-31 was $98.70M, a 10.65% increase year-over-year.
- STERIS plc payments to acquire property, plant, and equipment for the quarter ending 2025-09-30 was $86.50M, a 15.11% decline year-over-year.
- STERIS plc payments to acquire property, plant, and equipment for fiscal 2026 was $369.00M, a 0.30% decline from fiscal 2025.
- STERIS plc payments to acquire property, plant, and equipment for fiscal 2025 was $370.10M, a 2.72% increase from fiscal 2024.
- STERIS plc payments to acquire property, plant, and equipment for fiscal 2024 was $360.30M, a 0.46% decline from fiscal 2023.
- STERIS plc payments to acquire property, plant, and equipment for fiscal 2023 was $361.97M, a 25.87% increase from fiscal 2022.
| Period end | Payments to Acquire Property, Plant, and Equipment 3 month | Payments to Acquire Property, Plant, and Equipment 3 month as first filed | Payments to Acquire Property, Plant, and Equipment 6 month | Payments to Acquire Property, Plant, and Equipment 6 month as first filed | Payments to Acquire Property, Plant, and Equipment 9 month | Payments to Acquire Property, Plant, and Equipment 9 month as first filed | Payments to Acquire Property, Plant, and Equipment 12 month | Payments to Acquire Property, Plant, and Equipment 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $87.50M 10-Q · filed 2026-08-07 | $177.70M derived: sum of 2 quarters · filed 2026-08-07 | $276.40M derived: sum of 3 quarters · filed 2026-08-07 | $362.90M derived: sum of 4 quarters · filed 2026-08-07 | ||||
| 2026-03-31 | $90.20M derived: 10-K 12 month − 10-Q 9 month · filed 2026-05-29 | $188.90M derived: sum of 2 quarters · filed 2026-05-29 | $275.40M derived: sum of 3 quarters · filed 2026-05-29 | $369.00M 10-K · filed 2026-05-29 | ||||
| 2025-12-31 | $98.70M derived: 10-Q 9 month − 10-Q 6 month · filed 2026-02-06 | $185.20M derived: sum of 2 quarters · filed 2026-02-06 | $278.80M 10-Q · filed 2026-02-06 | $349.70M derived: sum of 4 quarters · filed 2026-08-07 | ||||
| 2025-09-30 | $86.50M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-11-06 | $180.10M 10-Q · filed 2025-11-06 | $251.00M derived: sum of 3 quarters · filed 2026-08-07 | $340.20M derived: sum of 4 quarters · filed 2026-08-07 | ||||
| 2025-06-30 | $93.60M 10-Q · filed 2026-08-07 | $164.50M derived: sum of 2 quarters · filed 2026-08-07 | $253.70M derived: sum of 3 quarters · filed 2026-08-07 | $355.60M derived: sum of 4 quarters · filed 2026-08-07 | ||||
| 2025-03-31 | $70.90M derived: 10-K 12 month − 10-Q 9 month · filed 2026-05-29 | $160.10M derived: sum of 2 quarters · filed 2026-05-29 | $262.00M derived: sum of 3 quarters · filed 2026-05-29 | $370.10M 10-K · filed 2026-05-29 | $370.09M 10-K · filed 2025-05-29 | |||
| 2024-12-31 | $89.20M derived: 10-Q 9 month − 10-Q 6 month · filed 2026-02-06 | $191.10M derived: sum of 2 quarters · filed 2026-02-06 | $299.20M 10-Q · filed 2026-02-06 | $299.21M 10-Q · filed 2025-02-07 | $390.67M derived: sum of 4 quarters · filed 2026-05-29 | |||
| 2024-09-30 | $101.90M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-11-06 | $210.00M 10-Q · filed 2025-11-06 | $209.97M 10-Q · filed 2024-11-07 | $301.47M derived: sum of 3 quarters · filed 2026-05-29 | $420.41M derived: sum of 4 quarters · filed 2026-05-29 | |||
| 2024-06-30 | $108.10M 10-Q · filed 2025-08-07 | $108.08M 10-Q · filed 2024-08-08 | $199.57M derived: sum of 2 quarters · filed 2026-05-29 | $318.51M derived: sum of 3 quarters · filed 2026-05-29 | $401.80M derived: sum of 4 quarters · filed 2026-05-29 | |||
| 2024-03-31 | $91.47M derived: 10-K 12 month − 10-Q 9 month · filed 2026-05-29 | $210.41M derived: sum of 2 quarters · filed 2026-05-29 | $293.70M derived: sum of 3 quarters · filed 2026-05-29 | $360.30M 10-K · filed 2026-05-29 | $360.33M 10-K · filed 2024-05-29 | |||
| 2023-12-31 | $118.94M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-02-07 | $202.23M derived: sum of 2 quarters · filed 2025-02-07 | $268.83M 10-Q · filed 2025-02-07 | $340.28M derived: sum of 4 quarters · filed 2025-05-29 | ||||
| 2023-09-30 | $83.29M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-11-07 | $149.89M 10-Q · filed 2024-11-07 | $221.34M derived: sum of 3 quarters · filed 2025-05-29 | $313.16M derived: sum of 4 quarters · filed 2025-05-29 | ||||
| 2023-06-30 | $66.60M 10-Q · filed 2024-08-08 | $138.05M derived: sum of 2 quarters · filed 2025-05-29 | $229.87M derived: sum of 3 quarters · filed 2025-05-29 | $312.64M derived: sum of 4 quarters · filed 2025-05-29 | ||||
| 2023-03-31 | $71.45M derived: 10-K 12 month − 10-Q 9 month · filed 2025-05-29 | $163.27M derived: sum of 2 quarters · filed 2025-05-29 | $246.04M derived: sum of 3 quarters · filed 2025-05-29 | $361.97M 10-K · filed 2025-05-29 | ||||
| 2022-12-31 | $91.82M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-02-08 | $174.59M derived: sum of 2 quarters · filed 2024-02-08 | $290.52M 10-Q · filed 2024-02-08 | $363.59M derived: sum of 4 quarters · filed 2024-05-29 | ||||
| 2022-09-30 | $82.77M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-11-07 | $198.70M 10-Q · filed 2023-11-07 | $271.77M derived: sum of 3 quarters · filed 2024-05-29 | $352.89M derived: sum of 4 quarters · filed 2024-05-29 | ||||
| 2022-06-30 | $115.93M 10-Q · filed 2023-08-08 | $189.00M derived: sum of 2 quarters · filed 2024-05-29 | $270.13M derived: sum of 3 quarters · filed 2024-05-29 | $347.10M derived: sum of 4 quarters · filed 2024-05-29 | ||||
| 2022-03-31 | $73.07M derived: 10-K 12 month − 10-Q 9 month · filed 2024-05-29 | $154.19M derived: sum of 2 quarters · filed 2024-05-29 | $231.17M derived: sum of 3 quarters · filed 2024-05-29 | $287.56M 10-K · filed 2024-05-29 | ||||
| 2021-12-31 | $81.12M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-02-08 | $158.09M derived: sum of 2 quarters · filed 2023-02-08 | $214.49M 10-Q · filed 2023-02-08 | $289.26M derived: sum of 4 quarters · filed 2023-05-26 | ||||
| 2021-09-30 | $76.97M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-11-09 | $133.37M 10-Q · filed 2022-11-09 | $208.13M derived: sum of 3 quarters · filed 2023-05-26 | $261.88M derived: sum of 4 quarters · filed 2023-05-26 | ||||
| 2021-06-30 | $56.40M 10-Q · filed 2022-08-08 | $131.16M derived: sum of 2 quarters · filed 2023-05-26 | $184.91M derived: sum of 3 quarters · filed 2023-05-26 | $228.80M derived: sum of 4 quarters · filed 2023-05-26 | ||||
| 2021-03-31 | $74.77M derived: 10-K 12 month − 10-Q 9 month · filed 2023-05-26 | $128.52M derived: sum of 2 quarters · filed 2023-05-26 | $172.40M derived: sum of 3 quarters · filed 2023-05-26 | $239.26M 10-K · filed 2023-05-26 | ||||
| 2020-12-31 | $53.75M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-02-09 | $97.64M derived: sum of 2 quarters · filed 2022-02-09 | $164.50M 10-Q · filed 2022-02-09 | $225.36M derived: sum of 4 quarters · filed 2022-05-31 | ||||
| 2020-09-30 | $43.88M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-11-08 | $110.75M 10-Q · filed 2021-11-08 | $171.61M derived: sum of 3 quarters · filed 2022-05-31 | $227.09M derived: sum of 4 quarters · filed 2022-05-31 | ||||
| 2020-06-30 | $66.86M 10-Q · filed 2021-08-09 | $127.73M derived: sum of 2 quarters · filed 2022-05-31 | $183.21M derived: sum of 3 quarters · filed 2022-05-31 | $231.58M derived: sum of 4 quarters · filed 2022-05-31 | ||||
| 2020-03-31 | $60.87M derived: 10-K 12 month − 10-Q 9 month · filed 2022-05-31 | $116.35M derived: sum of 2 quarters · filed 2022-05-31 | $164.72M derived: sum of 3 quarters · filed 2022-05-31 | $214.52M 10-K · filed 2022-05-31 | ||||
| 2019-12-31 | $55.48M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-02-09 | $103.86M derived: sum of 2 quarters · filed 2021-02-09 | $153.65M 10-Q · filed 2021-02-09 | $230.13M derived: sum of 4 quarters · filed 2021-05-28 | ||||
| 2019-09-30 | $48.37M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-11-06 | $98.17M 10-Q · filed 2020-11-06 | $174.65M derived: sum of 3 quarters · filed 2021-05-28 | $225.33M derived: sum of 4 quarters · filed 2021-05-28 | ||||
| 2019-06-30 | $49.79M 10-Q · filed 2020-08-07 | $126.27M derived: sum of 2 quarters · filed 2021-05-28 | $176.96M derived: sum of 3 quarters · filed 2021-05-28 | $211.78M derived: sum of 4 quarters · filed 2021-05-28 | ||||
| 2019-03-31 | $76.48M derived: 10-K 12 month − 10-Q 9 month · filed 2021-05-28 | $127.17M derived: sum of 2 quarters · filed 2021-05-28 | $161.99M derived: sum of 3 quarters · filed 2021-05-28 | $189.72M 10-K · filed 2021-05-28 | ||||
| 2018-12-31 | $50.69M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-02-10 | $85.51M derived: sum of 2 quarters · filed 2020-02-10 | $113.24M 10-Q · filed 2020-02-10 | |||||
| 2018-09-30 | $34.82M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-11-07 | $62.55M 10-Q · filed 2019-11-07 | ||||||
| 2018-06-30 | $27.73M 10-Q · filed 2019-08-07 | |||||||
| 2018-03-31 | $165.46M 8-K · filed 2021-02-09 | |||||||
| 2017-03-31 | $172.90M 10-K · filed 2019-05-30 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ZIMMER BIOMET HOLDINGS, INC. (ZBH) | United States | $17.103B | 20.66 |
| ALIGN TECHNOLOGY INC (ALGN) | United States | $10.346B | 29.06 |
| MSA Safety Inc (MSA) | United States | $7.023B | 21.47 |
| ESTABLISHMENT LABS HOLDINGS INC. (ESTA) | $1.954B | -65.76 | |
| Cadre Holdings, Inc. (CDRE) | United States | $1.123B | 33.88 |
| Enovis CORP (ENOV) | United States | $1.053B | -1.18 |
| Anteris Technologies Global Corp. (AVR) | United States | $0.746B | |
| Sanara MedTech Inc. (SMTI) | United States | $0.323B | -6.81 |
| Inogen Inc (INGN) | United States | $0.139B | -7.00 |
| Conexeu Sciences Inc. (CNXU) | United States | $0.111B |